Drug Topics
MARCH 18, 2025
The top reported barriers to providing buprenorphine included regulatory and administrative, operational and attitudinal, and patient-related challenges.
STAT
MARCH 18, 2025
Private equity firms are acquiring facilities that care for people with intellectual or developmental disabilities at an alarming rate, according to a new report released Tuesday. The care industry for this population has been historically owned and operated by nonprofits and faith-based institutions. However, between 2013 and 2023, private equity firms made over 1,000 acquisitions of disability and elder care providers — a likely undercount, according to the report published by the Priva
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
MARCH 18, 2025
On both an individual and societal level, researchers explored how social, cultural, and ethnic determinants impact the treatment and management of obesity.
STAT
MARCH 18, 2025
When Ted Matthews came out of retirement in early 2023 to retake the helm of the rural Texas hospital where he’d started his health care career, it was something of a rescue mission. They were having bake sales to keep the place afloat. Staff were updating their resumes. At every board meeting, they’d decide which bills to pay. “It was the consensus that we were going to be that twenty-seventh rural hospital in Texas to close,” said Matthews, interim CEO of Anso
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
MARCH 18, 2025
A conversation with Lydia Newsom, PharmD, clinical associate professor of pharmacy practice at Mercer University College of Pharmacy.
STAT
MARCH 18, 2025
Sarepta Therapeutics said Tuesday that a 16-year-old boy died after receiving Elevidys, its gene therapy for Duchenne muscular dystrophy, the first known death linked to the treatment. The teenager suffered liver failure, a side effect that has been seen with other gene therapy treatments over the last two decades. Sarepta said in its statement that a recent cytomegalovirus infection could have also contributed to the patient’s death, putting him at heightened risk.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
STAT
MARCH 18, 2025
Three years ago, Arbor Biotechnologies CEO Devyn Smith appeared at the J.P. Morgan Healthcare Conference and laid out a grand vision: With $215 million in new capital, the biotech would push forward CRISPR-based drugs for a series of liver and brain diseases, beginning by filing for a first trial in under two years. It was, suffice to say, bold.
Drug Topics
MARCH 18, 2025
Pharmacists are resilient, community-focused professionals who played a pivotal role in navigating the unprecedented challenges of the COVID-19 pandemic.
STAT
MARCH 18, 2025
As a reformed hypochondriac, I’m extremely vulnerable to the allure of pharmaceutical ads. I self-referred for GLP-1s years ago after seeing advertisements, and even though I am a diabetic, what followed were horrific health outcomes: hospitalizations, extensive procedures, scans, MRIs, pancreatitis, anemia, and thousands in medical expenses.
Drug Topics
MARCH 18, 2025
The new approval is an oral suspension for patients with hypertension and left ventricular hypertrophy and for the treatment of diabetic nephropathy.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
The Checkup by Singlecare
MARCH 18, 2025
Raspberries are vibrant, juicy, and somewhat tart berries known for their rich fiber and antioxidant content. The berries are plucked and enjoyed as a healthy snack or topping on oatmeal and yogurt. But did you know that the leaves of the raspberry plant ( Rubus idaeus ) may have health benefits, too? You may have heard of red raspberry leaf tea. It is a caffeine-free herbal tea made from the dried leaves of the fruit-bearing plant.
The FDA Law Blog
MARCH 18, 2025
By Sara W. Koblitz Integral to the careful balance Congress struck when passing the Hatch-Waxman Amendments, the patent term extension (PTE) is intended to restore patent life that was consumed during regulatory review of an FDA-regulated product. Even though the PTE provisions established in the Drug Price Competition and Patent Restoration Act are forty-plus years old, courts are still grappling with questions about how to best implement the Patent Term Extension.
PharmaVoice
MARCH 18, 2025
Smaller biotechs are finding creative ways to fund R&D at a time when the traditional financing channels have become more constrictive.
European Pharmaceutical Review
MARCH 18, 2025
Novo Nordisk has regained full membership with the Association of the British Pharmaceutical Industry (ABPI), following suspension in 2023. This action resulted after the pharmaceutical company made serious breaches of the ABPI Code of Practice in 2021. The case was the eighth instance in the past four decades that the ABPIs board has issued this degree of sanction, the industry body highlighted upon announcing the news.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Hospital Pharmacy Europe
MARCH 18, 2025
In an era of rapid healthcare evolution, clinical pharmacy is at a crossroads in Europe, facing both unprecedented opportunities and pressing challenges, and Dr Monika Lutters, ESCP president, is at the forefront of these developments. Here, speaking to Gerry Hughes, she shares her insights on current clinical pharmacy challenges around expansion and integration of hospital pharmacists, and the exciting trajectory this branch of pharmacy is set to undertake in the years ahead.
The Checkup by Singlecare
MARCH 18, 2025
Tirzepatide and semaglutide have exploded in popularity over the past few years, primarily due to their weight loss benefits. Tirzepatide is the active ingredient in both Mounjaro and Zepbound , while semaglutide is the active ingredient in Ozempic , Wegovy , and Rybelsus (an oral medicine). These medications act like natural hormones in the body, regulating appetite and reducing food noise (intrusive thoughts about food that interfere with weight loss efforts).
Hospital Pharmacy Europe
MARCH 18, 2025
Scotlands first cardiology consultant pharmacist has been appointed by NHS Golden Jubilee to provide professional leadership and mentorship and improve patient outcomes across the region. Paul Forsyth, who has 20 years experience working with cardiac patients, most recently as a heart failure pharmacist and lead pharmacist in clinical cardiology (primary care) at NHS Greater Glasgow and Clyde, will work across organisational boundaries to support cardiology lead pharmacists in the west of Scotla
The Checkup by Singlecare
MARCH 18, 2025
For many people with pain or inflammation, healthcare providers often prescribe medications like diclofenac or naproxen. These drugs belong to a group called nonsteroidal anti-inflammatory drugs (NSAIDs). Diclofenac and naproxen may help reduce inflammation and relieve pain caused by conditions like arthritis, menstrual cramps, or migraines. While both medications can help people relieve pain and discomfort that interferes with daily activities, they may differ in various ways.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharmacy Times
MARCH 18, 2025
Treatment with HTD1801 resulted in significant reductions in the hemoglobin A1c level and improved key cardiometabolic and liver parameters.
The Checkup by Singlecare
MARCH 18, 2025
Muscle spasms and stiffness can be painful and uncomfortable, with healthcare providers often prescribing medications like cyclobenzaprine or baclofen to help. These drugs are muscle relaxants used to relieve spasms from musculoskeletal conditions, nerve problems, or spinal cord injuries. They help relax muscles and reduce pain, providing people with much-needed relief.
Pharma Marketing Network
MARCH 18, 2025
Introduction Reaching healthcare professionals (HCPs) in the pharmaceutical industry has become increasingly challenging due to strict regulations, evolving digital landscapes, and the growing demand for personalized content. However, pay per click advertising (PPC) presents a powerful and targeted solution for pharma marketers looking to engage HCPs efficiently.
The Checkup by Singlecare
MARCH 18, 2025
Semaglutide and tirzepatidethese drugs are all the rage right now. You may know people who have had great success using one of these drugs for weight loss, and you may think, if one weight loss drug is so beneficial, should I try both at the same time? Is a tirzepatide semaglutide combination right for me? Unfortunately, these drugs are not meant to be combined.
Pharmaceutical Technology
MARCH 18, 2025
AstraZeneca has entered an exclusive licence agreement with Alteogen involving the latters ALT-B4 platform technology.
Fierce Healthcare
MARCH 18, 2025
After previously asking the court for time to review the case, a Monday filing saw the new administration carry the baton in a fight against drugmakers' controversial push for after-the-fact rebates rather than upfront discounts.
PhRMA
MARCH 18, 2025
The United States leads the world in the research, development and manufacturing of innovative medicines. But the Inflation Reduction Act’s (IRA) “pill penalty” puts this leadership at risk by discouraging the development of treatments that often come in pill form like a tablet or capsule, also known as small molecule medicines. Under the IRA, these treatments can be price set years before other medicines, signaling to researchers that developing them is not worth the risk.
Fierce Healthcare
MARCH 18, 2025
2024 was the year for ambient artificial intelligence medical scribes. | It built an open-source AI-enabled clinical copilot for clinicians, called Hyperscribe, and developed it with the Canvas software development kit.
pharmaphorum
MARCH 18, 2025
Stay informed about the latest information on NHS medicines spending in England, with a greater focus on the data provided by the NHS Business Services Authority (NHBSSA).
Pharmacy Times
MARCH 18, 2025
Reducing the dose of ibrutinib following adverse events improved tolerability without compromising clinical efficacy in chronic lymphocytic leukemia (CLL).
pharmaphorum
MARCH 18, 2025
Novo Nordisk has reached the end of its two-year suspension from the ABPI for breaches of its code of practice after making "sustained improvements"
Fierce Healthcare
MARCH 18, 2025
Google unveiled its latest health updates at its annual The Check Up event in Manhattan on Tuesday, including expanded support for medical records in its Health Connect service and open models to improve the efficiency of AI-powered drug discovery.
pharmaphorum
MARCH 18, 2025
Sofinnova Partners has raised 165m for its new biotech fund and backed three startups working on Alzheimer's, fibrotic diseases, and cell therapies
Pharmaceutical Technology
MARCH 18, 2025
Health Canada has granted approval for Biogens Skyclarys to treat Friedreichs ataxia (FA) in individuals aged 16 years and above.
Fierce Healthcare
MARCH 18, 2025
When Accenture surveyed C-suite level executives, it found significant gaps in the willingness to invest in the technology needed to accommodate generative AI and core business strategies for rolling out gen AI across their organizations.
Expert insights. Personalized for you.
468 
Let's personalize your content